IDeA Opportunity Fund I (2008)
Italian closed-end investment fund which takes minority stakes independently or alongside top-tier general partners. The investment team distinguishes itself for high financial management skills coupled with solid industrial and operational management capabilities.
Euticals is among the leading companies in Italy in the production of Active Principles Ingredients (API) for pharmaceutical industries operating in the generic drugs market and in the production of sterile API. Euticals produces about 80 active principles and holds a diversified and international client base of approximately 160 units. The company owns 11 plants certified GMP and based in Italy, France, Germany, United Kingdom and United States with a total of about 570 employees. In February 2011 Euticals acquired 100% of Archimica, a group active in the production of APIs and reactive for the pharmaceutical industry. The acquisition has allowed Euticals to achieve an established position worldwide and to develop its revenues with large pharmaceutical companies on a global basis.
